Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)
Investing Cash Flow
-$237.10M
TTM · Period ending: · USD
BIO Investing Cash Flow
Latest reported-$237.10Mperiod ending
Latest reported-$237.10Mperiod ending
BIO TTM Cash from Investing (-$17.60M → -$237.10M)
TTM investing cash flow
High-resolution chart · PNG
BIO investing cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Investing Cash Flow (USD) |
|---|---|
| 4,312,000 | |
| 7,019,000 | |
| 9,296,000 | |
| -202,092,000 | |
| -227,592,000 | |
| -225,983,000 | |
| -223,300,000 | |
| -18,900,000 | |
| -18,800,000 | |
| -22,900,000 | |
| -25,300,000 | |
| -56,500,000 | |
| -63,200,000 | |
| -57,400,000 | |
| -55,900,000 | |
| -24,200,000 | |
| -18,200,000 | |
| -17,100,000 | |
| -14,800,000 | |
| -12,000,000 | |
| -10,200,000 | |
| -12,600,000 | |
| -13,900,000 | |
| -14,500,000 | |
| -16,200,000 | |
| -14,200,000 | |
| -13,100,000 | |
| -11,300,000 | |
| -8,400,000 | |
| -11,700,000 | |
| -8,800,000 | |
| -7,100,000 | |
| -8,800,000 | |
| -9,100,000 | |
| -12,100,000 | |
| -17,600,000 | |
| -23,900,000 | |
| -23,400,000 | |
| -26,600,000 | |
| -27,400,000 | |
| -22,800,000 | |
| -19,600,000 | |
| -17,600,000 | |
| -14,200,000 | |
| -14,400,000 |